https://doi.org/10.1016/j.ebiom.2018.10.042
C
Chi‐Cheng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
130
Papers
1.3K
Citations
16
h-index
29
i10-index
Chi‐Cheng Li is an academic researcher from Tzu Chi University. The author has contributed to research in topics: Immune Cell Function and Interaction & T-cell and B-cell Immunology & Immunotherapy and Immune Responses. The author has an h-index of 16, co-authored 111 publications.
ORCID: 0000-0002-5022-1237Papers by this author
worksClinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
2018 · EBioMedicine · 105 citations
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
2019 · BMC Cancer · 84 citations
https://doi.org/10.1186/s12885-019-5822-y
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
2017 · Blood Cancer Journal · 50 citations
https://doi.org/10.1038/s41408-017-0022-y
SENP1 participates in Irinotecan resistance in human colon cancer cells
2021 · Journal of Cellular Biochemistry · 21 citations
https://doi.org/10.1002/jcb.29946
Calmodulin/CaMKII‐γ mediates prosurvival capability in apicidin‐persistent hepatocellular carcinoma cells via ERK1/2/CREB/c‐fos signaling pathway
2021 · Journal of Cellular Biochemistry · 14 citations
https://doi.org/10.1002/jcb.29892
Phosphorylation of Bcl‐2 by <scp>JNK</scp> confers gemcitabine resistance in lung cancer cells by reducing autophagy‐mediated cell death
2023 · Environmental Toxicology · 8 citations
https://doi.org/10.1002/tox.23836
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat